Medtech / devices
A new genetic therapy for Alzheimer’s is safe and successfully lowered levels of the harmful tau protein known to cause the disease, a new world first trial suggests. The researchers at University College London Hospitals (UCLH) NHS Foundation Trust and UCL, say the findings “are a significant step forward” in showing it may be possible [...]
A ground-breaking at-home 'earbud' test could pave the way for the early detection, diagnosis, prevention and treatment of serious brain diseases. Researchers are developing and testing a novel electroencephalogram (EEG) system similar to a pair of in-ear headphones that maps brain activity during sleep and could help diagnose neurodegenerative diseases such as Alzheimer's and Parkinson's [...]
South Korean scientists have made a potentially groundbreaking discovery that could change how Alzheimer’s disease is diagnosed and treated. The team from the Center for Cognition and Sociality within the Institute for Basic Science in Daejeon in central west South Korea, have discovered that reactive astrocytes rather than amyloid-beta plaques, may be the cause of [...]
A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Carb - short for Carbamathione - is a new formulation designed to treat ischemic stroke, protect brain tissue against injury and minimise the size of localised brain damage. About 87% of all strokes are caused [...]
A seven-figure funding boost to further develop a prostate cancer test could help save thousands of lives, its developers say. Despite being the most common malignancy other than skin cancer diagnosed in men, prostate cancer survival rates have improved little in the past four decades. But UK-based biotech firm Nanovery is hoping to turn the [...]
US biotech Alzamend Neuro has started a first of its kind phase 1/2a trial of an immunotherapy vaccine aimed at helping patients suffering with mild-to-moderate Alzheimer’s dementia fight the disease. The first-in-human, double-blind, placebo-controlled, randomised parallel group trial will enlist 20-30 participants to evaluate the safety, tolerability, and efficacy of the vaccine, known as ALZN002, [...]
Space was famously seen as the final frontier as the crew of the USS Enterprise boldly went where no man had gone before. Now UK scientists are looking to extend the boundaries of their knowledge as they reach for the stars in a bid to answer the enduring question of why people’s muscles deteriorate as [...]
New results from a large 10-year study show fall risk and incidence in older adults can be significantly reduced through a modest amount of a particular kind of computerised brain training. Falls are a big problem. The Centers for Disease Control reports that each year one of four seniors experience a fall, resulting in about [...]
Digital health company, NeuroRPM, has received FDA clearance for its artificial intelligence (AI)-powered remote monitoring app for Parkinson’s disease. The product uses AI and Apple Watch to continuously and passively monitor bradykinesia, tremor, and dyskinesia, the cardinal symptoms of Parkinson's disease. The product includes advanced, comprehensive monitoring capabilities for Parkinson’s disease available on a wearable [...]
A new spectroscopy probe, with optical fibres to provide real-time information to doctors, could enhance deep brain stimulation procedure for Parkinson’s disease patients. Deep brain stimulation (DBS) has become an increasingly common treatment for patients with advanced Parkinson’s disease, but the procedure still carries significant risks. A new probe that performs two types of spectroscopy [...]
